Skip to main content
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
2024
November 2024 Vol 17, Payers' Guide to FDA Updates
2023
December 2023 Vol 16, Payers' Guide to FDA Updates
September 2023 Vol 16, Payers' Guide to FDA Updates
June 2023 - Vol 16 No 1
Issue Archive
Topics
Conference Correspondent
ESMO 2024 - Small Cell Lung Cancer
EHA 2024 – Wrap-Up: Myelodysplastic Syndrome
ASCO 2024 – Wrap-Up: Myelodysplastic Syndrome
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
BCI and Adherence
Videos
-
Interview with the Innovators
Dr Stephen C. Malamud and Dr Susan K. Boolbol discuss the importance of using a clinically validated test such as the Breast Cancer Index
SM
(BCI) and its impact on patient confidence in their treatment plan.
Related Items
Patients Are at the Heart of Everything We Do
Jenny Fox
,
Wendy Interiano
,
Mark Peters II, PharmD
,
Shannon Stempkowski
Videos
published on
November 17, 2023
in
Interview with the Innovators
A Passion for Scientific Innovation and a Company Culture That Values Customers Drive the Teams at Genmab to Discover Cutting-Edge Solutions for People with Cancer
Brad Bailey
,
Chris Cozic
Videos
published on
October 19, 2022
in
Interview with the Innovators
Genmab Unleashes the Power of Strategic Alliances to Advance the Science of Therapeutic Antibodies for People with Cancer
Robyn Bilmes
,
Leslie Amendola
Videos
published on
September 28, 2022
in
Interview with the Innovators
Genmab Is Developing a World-Class Antibody Portfolio with the Hope to Bring the Right Cancer Therapy for the Right Patient
Kate Sasser
,
Hisham Hamadeh
Videos
published on
July 8, 2022
in
Interview with the Innovators
Genmab Is Ready to Enter the US Market to Help Improve the Lives of People with Cancer
Ron Graybill
,
Brad Bailey
Videos
published on
June 2, 2022
in
Interview with the Innovators
Last modified: August 30, 2021